The panel of experts for the U.S. Food and Drug Administration is
deciding whether to approve the Pfizer Covid-19 vaccine for children.
It could mean 5-11-year-olds are eligible for doses as early as next month.
Nick Harper reports from Washington.
IN: "Millions...."
OUT: SOC
DUR: 31 seconds
http://www.fsnradionews.com/feeds/1026pfizer-nh.mp3
The latest short-form news audio from FSN Bureaus worldwide